Corentec Co

Corentec Co FCF/Debt

The Free Cash Flow to Debt Ratio of Corentec Co (104540.KQ) as of Oct 16, 2026 is 507.10 %. In the previous year, Free Cash Flow to Debt Ratio was -48.24 % — a change of -1,151.21% (higher).

FCF/Debt

507.10 %

YoY

-1,151.21%

Last updated:

Free Cash Flow to Debt Ratio of Corentec Co is 2025 507.10 % . Free Cash Flow to Debt Ratio of Corentec Co was 2024 -48.24 % . It decreases by -1,151.21% higher compared to the previous year.

The Corentec Co FCF/Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF/Debt
Date
FCF/Debt
Jan 1, 2018
5.34 KRW
Jan 1, 2019
4.58 KRW
Jan 1, 2020
-30.29 KRW
Jan 1, 2021
-10.62 KRW
Jan 1, 2022
13.69 KRW
Jan 1, 2023
-53.60 KRW
Jan 1, 2024
-48.24 KRW
Jan 1, 2025
507.10 KRW
The Corentec Co FCF/Debt history
YEARFCF/DebtYoY
507.10 %-1,151.21%
-48.24 %-10.00%
-53.60 %-491.49%
13.69 %-228.87%
-10.62 %-64.93%
-30.29 %-760.79%
4.58 %-14.16%
5.34 %-115.52%
-34.40 %-31.77%
-50.42 %+3.57%
-48.68 %+38.10%
-35.25 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Corentec Co Stock analysis

What does Corentec Co do? Corentec Co Ltd is a South Korean company headquartered in Cheonan, operating within the Health Care sector. The company went public on March 5, 2013, as indicated by its IPO date. Corentec specializes in the manufacture and sale of artificial articulations, focusing on orthopedic products. Its product portfolio includes hip systems such as primary systems, hemi-arthroplasty systems, and revision systems, featuring cementless and cemented femoral stems, acetabular cups, and bearing systems. The company also offers knee products, comprising primary fixed and mobile type systems, revision knee systems, and augment systems. Additionally, Corentec provides spine products, including pedicle screws and peek cages. The firm markets its hip products under the BENCOX brand, while knee and spine products are sold under the LOSPA and LOSPA IS brand names, respectively. Corentec serves both domestic and international markets, distributing its products globally. The company's website is www.corentec.com. Corentec's business model centers on developing and commercializing orthopedic solutions for joint replacement and spinal care, with a focus on quality and innovation in medical devices. The company's operations are based in Cheonan, South Korea, and it has maintained a presence in the health care industry since its IPO in 2013. Corentec Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Corentec Co stock

Free Cash Flow to Debt Ratio of Corentec Co is 507.10 % in 2025.

Free Cash Flow to Debt Ratio of Corentec Co changed from -48.24 % to 507.10 %, representing a -1,151.21% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow to Debt Ratio Corentec Co since 2006 – with annual values, charts, and detailed analysis.

FCF/Debt measures the percentage of total debt that could be repaid from free cash flow. It is a stricter measure than OCF/Debt as it accounts for capital expenditures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow to Debt Ratio's Corentec Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Corentec Co

All Key Metrics — Corentec Co